|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1457607 |
USP |
Nateglinide 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1457618 |
USP |
Nateglinide Related Compound A - trans-4-isopropylcyclohexanecarboxylic acid 10 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1457629 |
USP |
Nateglinide Related Compound B - N-(trans-4-isopropylcyclohexanecarbonyl)-L-phenylalanine 10 mg |
|
873.33 CHF
917.00 €
|
|
|
|
USP-1457630 |
USP |
Nateglinide Related Compound C - N-(cis-4-isopropylcyclohexanecarbonyl)-D-phenylalanine 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1457695 |
USP |
Negundoside ((1S,4aS,7S,7aS)-1,4a,5,6,7,7a-Hexahydro-7-hydroxy-1-{[2-O-(4-hydroxybenzoyl)-beta-Dglucopyranosyl]oxy}-7-methylcyclopenta[c]pyran-4-carboxylic acid) 50 mg |
|
406.67 CHF
427.00 €
|
|
|
|
USP-1457709 |
USP |
Vitex negundo Leaf Dry Extract 3 g |
|
406.67 CHF
427.00 €
|
|
|
|
USP-1457797 |
USP |
Nebivolol Stereoisomer Mixture 15 mg |
|
1,514.67 CHF
1,590.40 €
|
|
|
|
USP-1457833 |
USP |
Nebivolol Hydrochloride 150 mg |
|
2,725.33 CHF
2,861.60 €
|
|
|
|
USP-1457844 |
USP |
Near IR System Suitability 1 unit |
|
3,650.67 CHF
3,833.20 €
|
|
|
|
USP-1457855 |
USP |
Nebivolol Related Compound A - A mixture of (S)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol Hydrochloride, (R,1S,1'S)-2,2'-Azanediylbis{1-[(R)-6-fluorochroman-2-yl]ethanol} Hydrochloride and (S,1R,1'R)-2,2'-Azanediylbis{1-[(S)- 6-fluorochroman-2-yl]ethanol} Hydrochloride 30 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1457866 |
USP |
Nebivolol Related Compound B - A mixture of (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride, (R)-1-[(R)-6-Fluorochroman-2-yl]-2-({(R)-2-[(R)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride and (S)-1-[(S)-6-Fluorochroman-2-yl]-2-({(S)-2-[(S)-6-fluorochroman-2-yl]-2-hydroxyethyl}amino)ethanol hydrochloride 30 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1457877 |
USP |
Nebivolol Related Compound C (COLD SHIPMENT REQUIRED) - ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) 100 mg |
|
1,648.00 CHF
1,730.40 €
|
|
|
|
USP-1457888 |
USP |
Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) 100 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1457899 |
USP |
Nebivolol Related Compound E - (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) 30 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1457902 |
USP |
Nefazodone Hydrochloride (HCl) 200 mg |
|
1,258.67 CHF
1,321.60 €
|
|
|
|
USP-1457913 |
USP |
Nefazodone Related Compound A - 1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride 25 mg |
|
842.67 CHF
884.80 €
|
|
|
|
USP-1457924 |
USP |
Nefazodone Related Compound B - 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride 25 mg |
|
842.67 CHF
884.80 €
|
|
|
|
USP-1458009 |
USP |
Neomycin Sulfate - Biologic 200 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1458019 |
USP |
Neomycin B ((2-Deoxy-4-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)-5-O-[3-O-(2,6-diamino-2,6-dideoxy-beta-Lidopyranosyl)-beta-D-ribofuranosyl]-D-streptamine sulfate) - Biologic 150 mg |
|
494.67 CHF
519.40 €
|
|
|
|
USP-1458020 |
USP |
Neomycin A 2,5 mg |
|
733.33 CHF
770.00 €
|
|
|
|
USP-1458031 |
USP |
Neomycin Sulfate System Suitability Mixture - Biologic 100 mg |
|
533.33 CHF
560.00 €
|
|
|
|
USP-1458042 |
USP |
Neohesperidin (30 mg) - (S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside 30 mg |
|
1,121.33 CHF
1,177.40 €
|
|
|
|
USP-1458064 |
USP |
Neodiosmin (5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-Dglucopyranoside) 30 mg |
|
509.33 CHF
534.80 €
|
|
|
|
USP-1458086 |
USP |
Neohesperidin Dihydrochalcone (3,5-Dihydroxy-4-[3-(3-hydroxy-4-methoxyphenyl)propanoyl]phenyl 2-O-(alpha-L-rhamnopyranosyl)-Beta-D-glucopyranoside) 500 mg |
|
630.67 CHF
662.20 €
|
|
|
|
USP-1459001 |
USP |
Neostigmine Bromide 200 mg |
|
302.67 CHF
317.80 €
|
|
|
|
USP-1460000 |
USP |
Neostigmine Methylsulfate ((m-Hydroxyphenyl)trimethylammonium methyl sulfate dimethylcarbamate) 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1460204 |
USP |
Neotame 200 mg |
|
512.00 CHF
537.60 €
|
|
|
|
USP-1460215 |
USP |
Neotame Related Compound A - N-[N-(3-3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 15 mg |
|
1,574.67 CHF
1,653.40 €
|
|
|
|
USP-1460317 |
USP |
Nepafenac 200 mg |
|
776.00 CHF
814.80 €
|
|
|
|
USP-1460328 |
USP |
Nepafenac Related Compound A (2-{2-Amino-3-[hydroxy(phenyl)methyl]phenyl}acetamide) 25 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1460339 |
USP |
Nepafenac Related Compound B (7-Benzoylindolin-2-one) 25 mg |
|
1,372.00 CHF
1,440.60 €
|
|
|
|
USP-1460500 |
USP |
Netilmicin Sulfate 500 mg |
|
508.00 CHF
533.40 €
|
|
|
|
USP-1460703 |
USP |
Nevirapine Anhydrous 100 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1460714 |
USP |
Nevirapine Hemihydrate 100 mg |
|
318.67 CHF
334.60 €
|
|
|
|
USP-1460725 |
USP |
Nevirapine Related Compound A - 5,11-Dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 15 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1460736 |
USP |
Nevirapine Related Compound B - 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one 10 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1460747 |
USP |
Nevirapine Related Compound C (15 mg) (5,11-Dihydro-6H-11-propyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one) 15 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1461003 |
USP |
Niacin 200 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1462006 |
USP |
Niacinamide (Vitamin B3, 3-Pyridinecarboxamide) 500 mg |
|
485.33 CHF
509.60 €
|
|
|
|
USP-1463224 |
USP |
Nicardipine Hydrochloride 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1463246 |
USP |
Nicardipine Related Compound B (3-{2-[Benzyl(methyl)amino]ethyl}5-methyl 2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate oxalate) 20 mg |
|
1,484.00 CHF
1,558.20 €
|
|
|
|
USP-1463268 |
USP |
Nicardipine Related Compound C (Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate) 10 mg |
|
1,297.33 CHF
1,362.20 €
|
|
|
|
USP-1463279 |
USP |
Nicardipine Related Compound D (Bis{2-[benzyl(methyl)amino]ethyl} 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate dihydrochloride) 10 mg |
|
1,361.33 CHF
1,429.40 €
|
|
|
|
USP-1463304 |
USP |
Nicotine Bitartrate Dihydrate ((pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:2), dihydrate)) 400 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1463326 |
USP |
Nicotine Related Compound A - (1,2,3,6-tetrahydro-2,3'-bipyridine) 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1463337 |
USP |
Nicotine Related Compound B - (3-(1-methyl-1H-pyrrol-2-yl)pyridine) 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1463348 |
USP |
Nicotine Related Compound C - ((S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one) 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1463359 |
USP |
Nicotine Related Compound D - (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate) 20 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1463360 |
USP |
Nicotine Related Compound E - ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate) 20 mg |
|
1,529.33 CHF
1,605.80 €
|
|
|
|
USP-1463371 |
USP |
Nicotine Related Compound F - (3-(pyrrolidin-2-yl)pyridine) 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
